These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 12633577)
21. Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors. Buglione M; Maddalo M; Mazzeo E; Bonomo P; Spiazzi L; Bruni A; Paiar F; Triggiani L; Greto D; Rubino L; Livi L; Bertoni F; Magrini SM Tumori; 2015; 101(5):585-92. PubMed ID: 26108237 [TBL] [Abstract][Full Text] [Related]
22. Prognostic factors and selection criteria in the retreatment of head and neck cancers. May ME; Cash ED; Silverman CL; Redman RA; Perez CA; Wilson LD; Tennant PA; Bumpous JM; Dunlap NE Oral Oncol; 2019 Jan; 88():85-90. PubMed ID: 30616802 [TBL] [Abstract][Full Text] [Related]
23. Treatment of recurrent head and neck cancer with 5-fluorouracil, hydroxyurea, and reirradiation. Weppelmann B; Wheeler RH; Peters GE; Kim RY; Spencer SA; Meredith RF; Salter MM Int J Radiat Oncol Biol Phys; 1992; 22(5):1051-6. PubMed ID: 1555952 [TBL] [Abstract][Full Text] [Related]
24. A review on re-irradiation for recurrent and second primary head and neck cancer. Kasperts N; Slotman B; Leemans CR; Langendijk JA Oral Oncol; 2005 Mar; 41(3):225-43. PubMed ID: 15743686 [TBL] [Abstract][Full Text] [Related]
25. Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer. Machtay M; Rosenthal DI; Chalian AA; Lustig R; Hershock D; Miller L; Weinstein GS; Weber RS Int J Radiat Oncol Biol Phys; 2004 May; 59(1):72-7. PubMed ID: 15093901 [TBL] [Abstract][Full Text] [Related]
26. Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911. Langer CJ; Harris J; Horwitz EM; Nicolaou N; Kies M; Curran W; Wong S; Ang K J Clin Oncol; 2007 Oct; 25(30):4800-5. PubMed ID: 17947728 [TBL] [Abstract][Full Text] [Related]
27. [Reirradiation of head and neck cancers]. Comet B; Lartigau E Cancer Radiother; 2010 Oct; 14(6-7):416-20. PubMed ID: 20810299 [TBL] [Abstract][Full Text] [Related]
28. Reirradiation of recurrent head and neck cancers with curative intent. Chmura SJ; Milano MT; Haraf DJ Semin Oncol; 2004 Dec; 31(6):816-21. PubMed ID: 15599860 [TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of HPV status in the re-irradiation of recurrent and second primary cancers of the head and neck. Velez MA; Wang PC; Hsu S; Chin R; Beron P; Abemayor E; St John M; Chen AM Am J Otolaryngol; 2018; 39(3):257-260. PubMed ID: 29433815 [TBL] [Abstract][Full Text] [Related]
30. Conformal re-irradiation of recurrent and new primary head-and-neck cancer. Dawson LA; Myers LL; Bradford CR; Chepeha DB; Hogikyan ND; Teknos TN; Terrell JE; Wolf GT; Eisbruch A Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):377-85. PubMed ID: 11380224 [TBL] [Abstract][Full Text] [Related]
31. Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma. De Crevoisier R; Domenge C; Wibault P; Koscielny S; Lusinchi A; Janot F; Bobin S; Luboinski B; Eschwege F; Bourhis J Cancer; 2001 Jun; 91(11):2071-6. PubMed ID: 11391587 [TBL] [Abstract][Full Text] [Related]
32. Reirradiation of recurrent tumors in the head and neck. Pomp J; Levendag PC; van Putten WL Am J Clin Oncol; 1988 Oct; 11(5):543-9. PubMed ID: 3177256 [TBL] [Abstract][Full Text] [Related]
33. Reirradiation of Recurrent and Second Primary Cancers of the Head and Neck: a Review of the Contemporary Evidence. Kreinbrink PJ; Lewis LM; Redmond KP; Takiar V Curr Treat Options Oncol; 2022 Mar; 23(3):295-310. PubMed ID: 35226310 [TBL] [Abstract][Full Text] [Related]
34. The role of re-irradiation of secondary and recurrent head and neck carcinomas. Is it a potentially curative treatment? A practical approach. Cacicedo J; Navarro A; Alongi F; Gómez de Iturriaga A; Del Hoyo O; Boveda E; Casquero F; Perez JF; Bilbao P Cancer Treat Rev; 2014 Feb; 40(1):178-89. PubMed ID: 23993769 [TBL] [Abstract][Full Text] [Related]
35. Recurrent head and neck cancer: retreatment of previously irradiated areas with combined chemotherapy and radiation therapy-results of a prospective study. Schaefer U; Micke O; Schueller P; Willich N Radiology; 2000 Aug; 216(2):371-6. PubMed ID: 10924555 [TBL] [Abstract][Full Text] [Related]
36. [Cytoprotection with amifostine in the framework of radiochemotherapy in previously irradiated head and neck carcinoma]. Büntzel J; Glatzel M; Schuth J; Weinaug R; Küttner K; Fröhlich D Strahlenther Onkol; 1999 Nov; 175 Suppl 4():37-40. PubMed ID: 10584140 [TBL] [Abstract][Full Text] [Related]
37. Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation. Choe KS; Haraf DJ; Solanki A; Cohen EE; Seiwert TY; Stenson KM; Blair EA; Portugal L; Villaflor VM; Witt ME; Vokes EE; Salama JK Cancer; 2011 Oct; 117(20):4671-8. PubMed ID: 21671479 [TBL] [Abstract][Full Text] [Related]
38. Efficacy and toxicity of reirradiation using intensity-modulated radiotherapy for recurrent or second primary head and neck cancer. Sher DJ; Haddad RI; Norris CM; Posner MR; Wirth LJ; Goguen LA; Annino D; Balboni T; Allen A; Tishler RB Cancer; 2010 Oct; 116(20):4761-8. PubMed ID: 20572036 [TBL] [Abstract][Full Text] [Related]
39. Interstitial low-dose-rate brachytherapy as a salvage treatment for recurrent head-and-neck cancers: long-term results. Puthawala A; Nisar Syed AM; Gamie S; Chen YJ; Londrc A; Nixon V Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):354-62. PubMed ID: 11567809 [TBL] [Abstract][Full Text] [Related]
40. [Treatment for recurrent head and neck carcinomas]. Tsukuda M Gan To Kagaku Ryoho; 1998 Feb; 25(3):303-8. PubMed ID: 9492820 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]